Differentiation and proliferation in mouse embryonal carcinoma cells
β Scribed by Merilyn J. Sleigh
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 856 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0265-9247
No coin nor oath required. For personal study only.
β¦ Synopsis
How cell commitment and differentiation are controlled in the early stages of embryogenesis is a problem that has long fascinated developmental biologists. Retinoic acidinduced differentiation of embryonal carcinoma cells in culture provides a model in which these questions can be explored. Recent work has yielded exciting insights into the central series of molecular changes which drives the commitment of these cells to formation of a new phenotype. Interacting with the key molecules in this central pathway is a variety of transcription factors, many of which show changes in availability and/or activity during differentiation. In various combinations, these modulate the activities of genes involved in both cell proliferation and in the production of extracellular matrix and other proteins characteristic of diflerentiated cells. ++ * 38.39 'Alternative names for binding factors are shown in brackets *Part of a family of factors binding to related sequences **A family of factors recognising related DNA sequences. Mcniberq of the family show variable changes in binding during F9 differentiationthe iiiost common patteni is indicated.
π SIMILAR VOLUMES
During embryonic development, cells not only increase in number, they also undergo specialization and differentiate into diverse cell types that are organized into different tissues and organs. Nervous system development, for example, involves a complex series of events such as neuronal and astrogli
## Abstract A clonal derivative named P19CL6 has been isolated from pluripotent P19 mouse embryonic carcinoma cells, and this subline efficiently differentiates into beating cardiomyocytes when treated with 1% dimethyl sulfoxide (DMSO). It offers a valuable model to study cardiomyocytes differentia
## Abstract ## BACKGROUND Hypoglycemia is a side effect of diabetes therapy and causes abnormal heart development. Embryonic heart cells are largely resistant to teratogenβinduced apoptosis. ## METHODS Hypoglycemia was tested for effects on cell death and cell proliferation in embryonic heart ce
derivatives. In this study, we report that each undiffer-\*To whom reprint requestskorrespondence should be addressed.